Post-marketing safety associated with sodium zirconium cyclosilicate: a pharmacovigilance study based on the FDA reporting system
This study confirmed SZC label safety warnings and identified new AEs, offering insights for clinical monitoring of SZC.
Authors
- Xiaoying Qin (ORCID: https://orcid.org/0000-0001-7148-002X)
- Taiyou Wang
- Jian‐Kang Chen (ORCID: https://orcid.org/0000-0001-9490-5588)
- Zuzhuang Lu
- Honghong Luo
Institutions
- National Research Center for Maternal and Child Health (KZ)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1080/14740338.2025.2486310
- Citations
- 2
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.04